TIRZEPATIDE

Tirzepatide is a synthetic peptide agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors used in scientific research to study incretin signaling and metabolic regulation. It is commonly utilized in laboratory settings to investigate pathways related to glucose homeostasis, insulin signaling, and energy balance. This compound is intended strictly for research purposes and is not approved for human or veterinary use outside of regulated clinical applications.

Research Applications

Incretin Receptor Signaling

Tirzepatide is used to study dual agonism of GIP and GLP-1 receptors, enabling investigation of synergistic effects on metabolic signaling pathways and hormone regulation.

Sources:

• https://pubmed.ncbi.nlm.nih.gov/33657293/

• https://pubmed.ncbi.nlm.nih.gov/31844193/

Glucose Homeostasis & Insulin Signaling

Research involving Tirzepatide focuses on its effects on insulin secretion, glucose uptake, and overall glycemic control mechanisms in experimental models.

Sources:

• https://pubmed.ncbi.nlm.nih.gov/33657293/

• https://pubmed.ncbi.nlm.nih.gov/33891252/

Energy Balance & Metabolic Regulation

Tirzepatide is utilized in studies exploring pathways related to energy intake, nutrient utilization, and metabolic efficiency through incretin-based mechanisms.

Sources:

• https://pubmed.ncbi.nlm.nih.gov/31844193/

• https://pubmed.ncbi.nlm.nih.gov/33891252/

Endocrine & Hormonal Pathways

The compound is applied in research examining interactions between incretin hormones and broader endocrine signaling systems, including pancreatic and gastrointestinal hormone regulation.

Sources:

• https://pubmed.ncbi.nlm.nih.gov/33657293/

• https://pubmed.ncbi.nlm.nih.gov/31844193/